title: Glutathione modified CdTe quantum dots as a label for studying DNA interactions with platinum based cytostatics.
abstract: Cisplatin, carboplatin, and oxaliplatin represent three generations of platinum based drugs applied successfully for cancer treatment. As a consequence of the employment of platinum based cytostatics in the cancer treatment, it became necessary to study the mechanism of their action. Current accepted opinion is the formation of Pt-DNA adducts, but the mechanism of their formation is still unclear. Nanomaterials, as a progressively developing branch, can offer a tool for studying the interactions of these drugs with DNA. In this study, fluorescent CdTe quantum dots (QDs, λem = 525 nm) were employed to investigate the interactions of platinum cytostatics (cisplatin, carboplatin, and oxaliplatin) with DNA fragment (500 bp, c = 25 μg/mL). Primarily, the fluorescent behavior of QDs in the presence of platinum cytostatics was monitored and major differences in the interaction of QDs with tested drugs were observed. It was found that the presence of carboplatin (c = 0.25 mg/mL) had no significant influence on QDs fluorescence; however cisplatin and oxaliplatin quenched the fluorescence significantly (average decrease of 20%) at the same concentration. Subsequently, the amount of platinum incorporated in DNA was determined by QDs fluorescence quenching. Best results were reached using oxaliplatin (9.4% quenching). Linear trend (R(2) = 0.9811) was observed for DNA platinated by three different concentrations of oxaliplatin (0.250, 0.125, and 0.063 mg/mL). Correlation with differential pulse voltammetric measurements provided linear trend (R(2) = 0.9511). As a conclusion, especially in the case of oxaliplatin-DNA adducts, the quenching was the most significant compared to cisplatin and nonquenching carboplatin.
authors: Department of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Brno, Czech Republic.
authors: Marketa
authors: M
authors: Ryvolova
authors: Kristyna
authors: K
authors: Smerkova
authors: Jana
authors: J
authors: Chomoucka
authors: Jaromir
authors: J
authors: Hubalek
authors: Vojtech
authors: V
authors: Adam
authors: Rene
authors: R
authors: Kizek
mesh_terms: D016190:Carboplatin / Q000032:analysis* / Q000378:metabolism; D002945:Cisplatin / Q000032:analysis / Q000378:metabolism; D054697:Cytostatic Agents / Q000032:analysis* / Q000378:metabolism*; D018736:DNA Adducts / Q000032:analysis* / Q000737:chemistry; D004563:Electrochemistry / Q000379:methods; D004587:Electrophoresis, Agar Gel / Q000379:methods; D019075:Electrophoresis, Capillary / Q000379:methods*; D005453:Fluorescence; D005978:Glutathione / Q000737:chemistry*; D009944:Organoplatinum Compounds / Q000032:analysis* / Q000737:chemistry / Q000378:metabolism; D000077150:Oxaliplatin; D045663:Quantum Dots
chemical_list: D054697:Cytostatic Agents; D018736:DNA Adducts; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D016190:Carboplatin; D005978:Glutathione; D002945:Cisplatin